203 related articles for article (PubMed ID: 18393288)
21. Targeting lipid metabolism in the treatment of hepatitis C virus infection.
Amemiya F; Maekawa S; Itakura Y; Kanayama A; Matsui A; Takano S; Yamaguchi T; Itakura J; Kitamura T; Inoue T; Sakamoto M; Yamauchi K; Okada S; Yamashita A; Sakamoto N; Itoh M; Enomoto N
J Infect Dis; 2008 Feb; 197(3):361-70. PubMed ID: 18248300
[TBL] [Abstract][Full Text] [Related]
22. [Investigating the inhibitory effects of interferon-alpha on the replication of hepatitis C virus replicon].
Jia YT; Wei L; Jiang D; Cong X; Fei R
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(29):2065-9. PubMed ID: 16313804
[TBL] [Abstract][Full Text] [Related]
23. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes.
Watashi K; Hijikata M; Hosaka M; Yamaji M; Shimotohno K
Hepatology; 2003 Nov; 38(5):1282-8. PubMed ID: 14578868
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of inducible nitric oxide synthase (iNOS) expression is implicated in the antiviral activity of acetylsalicylic acid in HCV-expressing cells.
Ríos-Ibarra CP; Lozano-Sepulveda S; Muñoz-Espinosa L; Rincón-Sánchez AR; Cordova-Fletes C; Rivas-Estilla AM
Arch Virol; 2014 Dec; 159(12):3321-8. PubMed ID: 25106115
[TBL] [Abstract][Full Text] [Related]
25. Multiple effects of Honokiol on the life cycle of hepatitis C virus.
Lan KH; Wang YW; Lee WP; Lan KL; Tseng SH; Hung LR; Yen SH; Lin HC; Lee SD
Liver Int; 2012 Jul; 32(6):989-97. PubMed ID: 22098176
[TBL] [Abstract][Full Text] [Related]
26. (-)-Epigallocatechin-3-gallate inhibits the replication cycle of hepatitis C virus.
Chen C; Qiu H; Gong J; Liu Q; Xiao H; Chen XW; Sun BL; Yang RG
Arch Virol; 2012 Jul; 157(7):1301-12. PubMed ID: 22491814
[TBL] [Abstract][Full Text] [Related]
27. [The direct antiviral effect of interferon-gamma on hepatitis C virus replicon].
Jia YT; Wei L; Jiang D; Cong X; Fei R
Zhonghua Gan Zang Bing Za Zhi; 2006 Jan; 14(1):7-10. PubMed ID: 16420756
[TBL] [Abstract][Full Text] [Related]
28. Interferon regulatory factor 3-independent double-stranded RNA-induced inhibition of hepatitis C virus replicons in human embryonic kidney 293 cells.
Ali S; Kukolj G
J Virol; 2005 Mar; 79(5):3174-8. PubMed ID: 15709037
[TBL] [Abstract][Full Text] [Related]
29. Identification of host genes involved in hepatitis C virus replication by small interfering RNA technology.
Ng TI; Mo H; Pilot-Matias T; He Y; Koev G; Krishnan P; Mondal R; Pithawalla R; He W; Dekhtyar T; Packer J; Schurdak M; Molla A
Hepatology; 2007 Jun; 45(6):1413-21. PubMed ID: 17518369
[TBL] [Abstract][Full Text] [Related]
30. Comparative analysis of intracellular inhibition of hepatitis C virus replication by small interfering RNAs.
Chang B; Lee CH; Lee JH; Lee SW
Biotechnol Lett; 2010 Sep; 32(9):1231-7. PubMed ID: 20464448
[TBL] [Abstract][Full Text] [Related]
31. Oxidative stress induces anti-hepatitis C virus status via the activation of extracellular signal-regulated kinase.
Yano M; Ikeda M; Abe K; Kawai Y; Kuroki M; Mori K; Dansako H; Ariumi Y; Ohkoshi S; Aoyagi Y; Kato N
Hepatology; 2009 Sep; 50(3):678-88. PubMed ID: 19492433
[TBL] [Abstract][Full Text] [Related]
32. Thromboxane A2 synthase inhibitors prevent production of infectious hepatitis C virus in mice with humanized livers.
Abe Y; Aly HH; Hiraga N; Imamura M; Wakita T; Shimotohno K; Chayama K; Hijikata M
Gastroenterology; 2013 Sep; 145(3):658-67.e11. PubMed ID: 23684750
[TBL] [Abstract][Full Text] [Related]
33. Relationships between hepatitis C virus replication and CXCL-8 production in vitro.
Koo BC; McPoland P; Wagoner JP; Kane OJ; Lohmann V; Polyak SJ
J Virol; 2006 Aug; 80(16):7885-93. PubMed ID: 16873245
[TBL] [Abstract][Full Text] [Related]
34. Celastrol inhibits hepatitis C virus replication by upregulating heme oxygenase-1 via the JNK MAPK/Nrf2 pathway in human hepatoma cells.
Tseng CK; Hsu SP; Lin CK; Wu YH; Lee JC; Young KC
Antiviral Res; 2017 Oct; 146():191-200. PubMed ID: 28935193
[TBL] [Abstract][Full Text] [Related]
35. [Inhibition of hepatitis C virus replication by mycophenolic acid in hepatocytes].
Chen H; Ye L; Su JM; Li Y; Zeng JR; Huo WZ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Feb; 27(1):35-8. PubMed ID: 23855126
[TBL] [Abstract][Full Text] [Related]
36. Sequence-specific cleavage of hepatitis C virus RNA by DNAzymes: inhibition of viral RNA translation and replication.
Roy S; Gupta N; Subramanian N; Mondal T; Banerjea AC; Das S
J Gen Virol; 2008 Jul; 89(Pt 7):1579-1586. PubMed ID: 18559927
[TBL] [Abstract][Full Text] [Related]
37. Andrographolide exerts anti-hepatitis C virus activity by up-regulating haeme oxygenase-1 via the p38 MAPK/Nrf2 pathway in human hepatoma cells.
Lee JC; Tseng CK; Young KC; Sun HY; Wang SW; Chen WC; Lin CK; Wu YH
Br J Pharmacol; 2014 Jan; 171(1):237-52. PubMed ID: 24117426
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis C virus replication is directly inhibited by IFN-alpha in a full-length binary expression system.
Chung RT; He W; Saquib A; Contreras AM; Xavier RJ; Chawla A; Wang TC; Schmidt EV
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9847-52. PubMed ID: 11493707
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis c virus genotype 4 replication in the hepatocellular carcinoma cell line HepG2/C3A.
Shier MK; El-Wetidy MS; Ali HH; Al-Qattan MM
Saudi J Gastroenterol; 2016; 22(3):240-8. PubMed ID: 27184644
[TBL] [Abstract][Full Text] [Related]
40. [Antiviral activities of ISG20 against hepatitis C virus].
Xu H; Lei Y; Zhong S; Peng FY; Zhou Z; Li K; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2013 Jan; 21(1):33-7. PubMed ID: 23663760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
